Monopar Therapeutics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MNPR research report →
About the company
Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, which is in phase 1 imaging and dosimetry clinical trial, a radiopharmaceutical imaging agent comprised of MNPR-101 conjugated to zirconium-89.
- CEO
- Chandler D. Robinson
- IPO
- 2019
- Employees
- 22
- HQ
- Wilmette, IL, US
Price Chart
- Market Cap
- $655.10M
- P/E
- -47.24
- P/S
- 0.00
- P/B
- 6.16
- EV/EBITDA
- -38.53
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -12.84%
- ROIC
- -13.80%
- Revenue
- $0 · 0.00%
- Net Income
- $-13,716,894 · 11.99%
- EPS
- $-1.85 · -36.03%
- Op Income
- $-16,704,415
- FCF YoY
- -90.52%
- 52W High
- $105.00
- 52W Low
- $29.18
- 50D MA
- $64.96
- 200D MA
- $68.57
- Beta
- 1.48
- Avg Volume
- 172.31K
Get TickerSpark's AI analysis on MNPR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Vu Quan Anh | other | 1,228 |
| Jun 30, 26 | Vu Quan Anh | other | 1,228 |
| Jun 30, 26 | Vu Quan Anh | other | 507 |
| Jun 30, 26 | Robinson Chandler | other | 12,873 |
| Jun 30, 26 | Robinson Chandler | other | 4,084 |
| Jun 30, 26 | Robinson Chandler | other | 12,873 |
| Jun 30, 26 | Cittadine Andrew | other | 5,254 |
| Jun 30, 26 | Cittadine Andrew | other | 2,309 |
| Jun 30, 26 | Cittadine Andrew | other | 5,254 |
| Jun 26, 26 | Sweeny Nicole | other | 1,284 |
Our MNPR coverage
Recent articles, reports, and earnings notes.
No research on MNPR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MNPR report →Similar companies
Peers in the same neighborhood.